Open-label study of donepezil in chronic poststroke aphasia.
Berthier
Marcelo L
ML
Department of Medicine, University of Malaga School of Medicine, Spain. mberthier@terra.es
Hinojosa
Julían
J
Martín
María del Carmen
Mdel C
Fernández
Inmaculada
I
D000328:Adult; D000368:Aged; D001037:Aphasia / Q000188:drug therapy* / Q000209:etiology; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D000077265:Donepezil; D005260:Female; D006801:Humans; D007189:Indans / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D018697:Nootropic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D010865:Pilot Projects; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use*; D012720:Severity of Illness Index; D020521:Stroke / Q000150:complications*; D016896:Treatment Outcome
D002800:Cholinesterase Inhibitors; D007189:Indans; D018697:Nootropic Agents; D010880:Piperidines; D000077265:Donepezil